Siyu Wu

138 Yi Xue Yuan Road
Xuhui, 200032, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 10 publications

On-treatment core needle biopsy identifies early responders for axillary surgery de-escalation: results from a prospective cohort.

On-treatment core needle biopsy identifies early responders for axillary surgery de-escalation: results from a prospective cohort.

Journal: British journal of cancer

Published: November 02, 2025

Development and validation of peritumoral vascular and intratumoral radiomics to predict pathologic complete responses to neoadjuvant chemotherapy in patients with triple-negative breast cancer.

Development and validation of peritumoral vascular and intratumoral radiomics to predict pathologic complete responses to neoadjuvant chemotherapy in patients with triple-negative breast cancer.

Journal: BMC medical imaging

Published: February 16, 2024

Optimal Duration of Neoadjuvant Taxane and Carboplatin Combined With Anti-HER2 Targeted Therapy for HER2-Positive Breast Cancer.

Optimal Duration of Neoadjuvant Taxane and Carboplatin Combined With Anti-HER2 Targeted Therapy for HER2-Positive Breast Cancer.

Journal: Frontiers in oncology

Published: March 27, 2021

The use of a second core needle biopsy to predict response to neoadjuvant chemotherapy in breast cancer patients, especially in the HER2-positive population.

The use of a second core needle biopsy to predict response to neoadjuvant chemotherapy in breast cancer patients, especially in the HER2-positive population.

Journal: Surgery

Published: February 28, 2020

Subtype-Guided 18 F-FDG PET/CT in Tailoring Axillary Surgery Among Patients with Node-Positive Breast Cancer Treated with Neoadjuvant Chemotherapy: A Feasibility Study.

Subtype-Guided 18 F-FDG PET/CT in Tailoring Axillary Surgery Among Patients with Node-Positive Breast Cancer Treated with Neoadjuvant Chemotherapy: A Feasibility Study.

Journal: The oncologist

Published: July 30, 2019

ASO Author Reflections: Tailoring of Targeted Axillary Dissection-Intraoperative Nodal Evaluation Reduces Second Operations.

ASO Author Reflections: Tailoring of Targeted Axillary Dissection-Intraoperative Nodal Evaluation Reduces Second Operations.

Journal: Annals of surgical oncology

Published: September 19, 2018

Intraoperative Touch Imprint Cytology in Targeted Axillary Dissection After Neoadjuvant Chemotherapy for Breast Cancer Patients with Initial Axillary Metastasis.

Intraoperative Touch Imprint Cytology in Targeted Axillary Dissection After Neoadjuvant Chemotherapy for Breast Cancer Patients with Initial Axillary Metastasis.

Journal: Annals of surgical oncology

Published: January 26, 2018

Sequential versus simultaneous use of chemotherapy and gonadotropin-releasing hormone agonist (GnRHa) among estrogen receptor (ER)-positive premenopausal breast cancer patients: effects on ovarian function, disease-free survival, and overall survival.

Sequential versus simultaneous use of chemotherapy and gonadotropin-releasing hormone agonist (GnRHa) among estrogen receptor (ER)-positive premenopausal breast cancer patients: effects on ovarian function, disease-free survival, and overall survival.

Journal: Breast cancer research and treatment

Published: November 13, 2017

Local recurrence following mastectomy and autologous breast reconstruction: incidence, risk factors, and management.

Local recurrence following mastectomy and autologous breast reconstruction: incidence, risk factors, and management.

Journal: OncoTargets and therapy

Published: November 18, 2016

Low rate of positive margins and re-excision after partial mastectomy in highly selected breast cancer patients: A Chinese single-institution experience.

Low rate of positive margins and re-excision after partial mastectomy in highly selected breast cancer patients: A Chinese single-institution experience.

Journal: Oncotarget

Published: June 29, 2016

Showing 1-10 of 10

Last Updated: 09/26/2026